• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00534240
Medical Device Problem Code Migration (4003)
Health Effect - Clinical Code Pain (1994)
Date of Event 11/02/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf device code a010402 captures the reportable event of stent migration.Imdrf impact code f23 captures the reportable event of another procedure performed to remove the stent.
 
Event or Problem Description
Note: this report pertains to one of two devices used during the same procedure.It was reported to boston scientific corporation that two advanix-naviflex rx biliary stents were implanted in the right and left hepatic ducts to treat a stricture during an endoscopic retrograde cholangiopancreatography (ercp) procedure performed on (b)(6) 2023.On (b)(6) 2023, a day post-stent placement, the patient experienced pain.Imaging was performed, and it was noted that one stent migrated and perforated the duodenum, and the other stent also migrated.On (b)(6) 2023, another procedure was performed.The stents were removed using rat-tooth forceps, and the perforation was closed using an ovesco clip.No additional stents were implanted in place of the migrated stents.In the physician's assessment, the patient's complication is related to the device and procedure.The patient's condition at the conclusion of the procedure was reported to be fully recovered.
 
Event or Problem Description
Note: this report pertains to one of two devices used during the same procedure.It was reported to boston scientific corporation that two advanix-naviflex rx biliary stents were implanted in the right and left hepatic ducts to treat a stricture during an endoscopic retrograde cholangiopancreatography (ercp) procedure performed on (b)(6) 2023.On (b)(6) 2023, a day post-stent placement, the patient experienced pain.Imaging was performed, and it was noted that one stent migrated and perforated the duodenum, and the other stent also migrated.On (b)(6) 2023, another procedure was performed.The stents were removed using rat-tooth forceps, and the perforation was closed using an ovesco clip.No additional stents were implanted in place of the migrated stents.In the physician's assessment, the patient's complication is related to the device and procedure.The patient's condition at the conclusion of the procedure was reported to be fully recovered.
 
Additional Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf device code a010402 captures the reportable event of stent migration.Imdrf impact code f23 captures the reportable event of another procedure performed to remove the stent.Block h11: block g1 (mfr site address 1, mfr site city, mfr site state, mfr site zip/post code and mfr site country) has been corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANIX BILIARY
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18250715
Report Number3005099803-2023-06357
Device Sequence Number15231055
Product Code FGE
UDI-Device Identifier08714729787334
UDI-Public08714729787334
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K101314
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM00534240
Device Catalogue Number3424
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/07/2023
Supplement Date Received by Manufacturer12/11/2023
Initial Report FDA Received Date12/01/2023
Supplement Report FDA Received Date12/12/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-